Meclizine (Aspire Biopharma)

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameMeclizine (Aspire Biopharma)
Drug Alias NameFast-Acting Sublingual Powder Formulation of MeclizineDramamine (Aspire Biopharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsVomitingNauseaMotion Sickness +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAspire Biopharma Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesAspire Biopharma Holdings Inc
Inactive CompaniesN/A
Active IndicationsVomitingNauseaMotion Sickness +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A